Erythropoietin, VEGF, and Diabetic Retinopathy

[clic...@yahoo.com]

Inhibition of vascular endothelial growth factor (VEGF), a primary
mediator of retinal angiogenesis, is insufficient to prevent retinal
neovascularization.

Now, researchers have uncovered another suspected molecule as a retinal
angiogenic factor in proliferative diabetic retinopathy, a new study
published in the journal New England Journal of Medicine.

>> More:
http://www.webmedtoday.com/advmedsci/BioMolecules/BM0508016.htm

>> talk:
http://www.webmedtoday.com/forum/viewtopic.php?t=94